Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Zymeworks Inc.

ZYME Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ZYME by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ZYME Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ZYME Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ZYME Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ZYME holdings by institutional investors

Quarterly net insider trading by ZYME's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ZYME

Quiver Logo

No former government officials on record as having lobbied for ZYME

Revolving Door Dashboard

ZYME Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ZYME Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ZYME Income Statement
ZYME Balance Sheet
ZYME Cash Flow
U.S. Patents

New ZYME patent grants

  • Patent Title: Bispecific antigen-binding constructs targeting her2 May. 10, 2022
  • Patent Title: Modified antigen binding polypeptide constructs and uses thereof Apr. 19, 2022
  • Patent Title: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Mar. 29, 2022
  • Patent Title: Multivalent heteromultimer scaffold design and constructs Feb. 15, 2022
  • Patent Title: Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof Nov. 02, 2021
  • Patent Title: Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics Oct. 19, 2021
  • Patent Title: Drug-conjugated bi-specific antigen-binding constructs Oct. 19, 2021
  • Patent Title: Heteromultimers with reduced or silenced effector function Aug. 24, 2021
  • Patent Title: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Aug. 03, 2021
  • Patent Title: Systems and methods for identifying thermodynamically relevant polymer conformations Jun. 08, 2021
  • Patent Title: Antigen-binding constructs targeting her2 Jun. 08, 2021
  • Patent Title: Anti-her2 biparatopic antibody-drug conjugates and methods of use May. 11, 2021
  • Patent Title: Bispecific antigen-binding constructs targeting her2 Mar. 16, 2021
  • Patent Title: Stable heterodimeric antibody design with mutations in the fc domain Dec. 29, 2020
  • Patent Title: System for molecular packing calculations Nov. 10, 2020
  • Patent Title: Multivalent heteromultimer scaffold design and constructs Jul. 14, 2020
  • Patent Title: Compositions and methods for the treatment of platinum-drug resistant cancer Dec. 31, 2019
  • Patent Title: Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells Dec. 17, 2019
  • Patent Title: Systems and methods for sampling and analysis of polymer conformational dynamics Nov. 19, 2019
  • Patent Title: Stable heterodimeric antibody design with mutations in the fc domain Oct. 29, 2019
  • Patent Title: Cytotoxic and anti-mitotic compounds, and methods of using the same Oct. 22, 2019
  • Patent Title: Cytotoxic and anti-mitotic compounds, and methods of using the same Sep. 17, 2019
  • Patent Title: Multivalent heteromultimer scaffold design and constructs Jul. 23, 2019
  • Patent Title: Monovalent antigen binding constructs targeting egfr and/or her2 and uses thereof Apr. 30, 2019
  • Patent Title: Systems and methods for in silico evaluation of polymers Apr. 09, 2019
  • Patent Title: Systems and methods for making two dimensional graphs of complex molecules Apr. 09, 2019
  • Patent Title: Bispecific her2 and her3 antigen binding constructs Mar. 26, 2019
  • Patent Title: Cytotoxic and anti-mitotic compounds, and methods of using the same Feb. 12, 2019
  • Patent Title: Systems and methods for making two dimensional graphs of complex molecules Jan. 01, 2019
  • Patent Title: Multivalent heteromultimer scaffold design and constructs Dec. 18, 2018
  • Patent Title: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Sep. 18, 2018
  • Patent Title: Simplifying residue relationships in protein design Jun. 19, 2018
  • Patent Title: Bispecific antigen-binding constructs targeting her2 Jun. 19, 2018
  • Patent Title: Crystal structures of heterodimeric fc domains Jun. 05, 2018
  • Patent Title: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Mar. 13, 2018
  • Patent Title: Cytotoxic and anti-mitotic compounds, and methods of using the same Jan. 30, 2018
  • Patent Title: Methods of quantitating heavy and light chain polypeptide pairs Sep. 26, 2017
  • Patent Title: Crystal structures of heterodimeric fc domains Aug. 15, 2017
  • Patent Title: Systems and methods for identifying thermodynamic effects of atomic changes to polymers Jul. 04, 2017
  • Patent Title: Stable heterodimeric antibody design with mutations in the fc domain Feb. 21, 2017
  • Patent Title: Stable heterodimeric antibody design with mutations in the fc domain Feb. 07, 2017
  • Patent Title: Cytotoxic and anti-mitotic compounds, and methods of using the same Dec. 20, 2016
  • Patent Title: Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells Nov. 22, 2016
  • Patent Title: Multivalent heteromultimer scaffold design and constructs Nov. 22, 2016
  • Patent Title: Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics Aug. 02, 2016
  • Patent Title: Multivalent heteromultimer scaffold design and constructs Jul. 12, 2016
  • Patent Title: Antibodies with enhanced or suppressed effector function Mar. 29, 2016
  • Patent Title: Density based clustering for multidimensional data Oct. 20, 2015
  • Patent Title: System and method for modeling interactions Aug. 03, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ZYME from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ZYME News

Recent insights relating to ZYME

CNBC Recommendations

Recent picks made for ZYME stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ZYME

ZYME Analyst Ratings

ZYME Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ZYME Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ZYME stock a Buy, Sell, or Hold?

  • What is the price target for $ZYME stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ZYME Top Shareholders
Shareholder
Shares Held
ZYME Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ZYME stock?

  • Who owns the most shares of $ZYME stock?

  • What funds own $ZYME stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ZYME Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ZYME Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ZYME

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

  • Address Middletown, DE
  • Market Cap 1.9 billion
  • Employees 264
  • Industrial Classification Pharmaceutical Preparations

Zymeworks Inc. (ZYME) Historical Stock Prices

Zymeworks Inc. (ZYME) closed at $26.81 on September 24, 2026. Over the past year its adjusted close ranged from $16.16 to $31.05. Daily prices go back to April 28, 2017, 2,365 trading days in all.

  • 1 month-2.40%
  • 3 months+12.79%
  • Year to date+1.82%
  • 1 year+64.48%
  • 3 years+320.22%
  • 5 years-6.00%
  • Max+106.23%
See every congressional and insider trade on the ZYME price chart

Quiver Premium charts ZYME's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 27.13 27.50 26.14 26.81 26.81 752,933
Sep 23, 2026 27.55 27.89 26.52 27.50 27.50 647,747
Sep 22, 2026 26.72 27.70 26.55 27.57 27.57 446,027
Sep 21, 2026 26.84 27.17 26.19 26.81 26.81 582,617
Sep 18, 2026 27.45 27.55 26.38 26.57 26.57 1,096,079
Sep 17, 2026 27.15 27.86 26.71 27.48 27.48 1,330,355
Sep 16, 2026 26.17 26.55 25.91 26.24 26.24 686,993
Sep 15, 2026 26.61 26.79 25.81 26.05 26.05 552,157
Sep 14, 2026 26.80 27.14 26.23 26.85 26.85 711,026
Sep 11, 2026 26.62 26.99 26.03 26.24 26.24 1,030,812
Sep 10, 2026 26.81 27.04 26.39 26.43 26.43 585,293
Sep 9, 2026 27.81 28.09 27.08 27.15 27.15 396,032
Sep 8, 2026 28.93 28.93 28.07 28.11 28.11 443,270
Sep 4, 2026 29.81 29.99 29.09 29.19 29.19 476,599
Sep 3, 2026 31.34 31.34 29.59 29.90 29.90 790,935
Sep 2, 2026 30.00 31.17 30.00 31.05 31.05 808,098
Sep 1, 2026 29.32 29.90 29.07 29.67 29.67 483,063
Aug 31, 2026 28.06 29.70 27.81 29.41 29.41 716,494
Aug 28, 2026 28.91 28.91 28.18 28.27 28.27 542,190
Aug 27, 2026 29.33 29.58 28.53 29.01 29.01 625,158
Aug 26, 2026 27.56 30.62 27.48 29.30 29.30 1,215,804
Aug 25, 2026 28.86 30.50 25.61 27.47 27.47 2,076,726
Aug 24, 2026 28.68 28.83 27.01 28.77 28.77 824,551
Aug 21, 2026 26.97 28.74 26.77 28.67 28.67 836,383
Aug 20, 2026 27.08 27.16 26.23 26.57 26.57 498,746
Aug 19, 2026 27.12 27.83 26.36 27.21 27.21 845,210
Aug 18, 2026 25.35 26.35 25.31 26.07 26.07 650,165
Aug 17, 2026 25.01 25.80 24.94 25.31 25.31 442,399
Aug 14, 2026 25.62 25.73 24.89 25.12 25.12 332,604
Aug 13, 2026 25.27 25.99 24.96 25.76 25.76 664,682
Aug 12, 2026 24.20 25.09 23.94 24.93 24.93 563,639
Aug 11, 2026 24.65 24.93 24.17 24.32 24.32 461,235
Aug 10, 2026 23.63 24.20 23.47 24.16 24.16 819,974
Aug 7, 2026 24.10 24.76 23.18 23.54 23.54 578,107
Aug 6, 2026 23.50 23.84 23.10 23.13 23.13 673,709
Aug 5, 2026 23.10 23.91 22.81 23.50 23.50 488,396
Aug 4, 2026 22.41 23.43 21.97 22.79 22.79 419,787
Aug 3, 2026 21.95 22.14 21.52 21.81 21.81 398,335
Jul 31, 2026 22.75 22.75 21.80 21.94 21.94 375,124
Jul 30, 2026 22.02 23.00 21.90 22.71 22.71 402,867
Jul 29, 2026 22.66 22.96 21.90 22.01 22.01 340,485
Jul 28, 2026 23.20 23.50 22.35 22.61 22.61 358,041
Jul 27, 2026 23.07 23.59 22.99 23.00 23.00 259,300
Jul 24, 2026 23.32 23.69 22.72 22.86 22.86 272,376
Jul 23, 2026 22.98 23.51 22.86 23.12 23.12 357,873
Jul 22, 2026 23.85 24.25 23.28 23.36 23.36 388,075
Jul 21, 2026 23.80 24.21 23.70 24.05 24.05 512,933
Jul 20, 2026 24.15 24.54 23.73 23.76 23.76 437,383
Jul 17, 2026 24.20 24.59 24.01 24.19 24.19 444,694
Jul 16, 2026 24.75 24.97 24.04 24.19 24.19 458,798
Jul 15, 2026 24.82 24.97 24.24 24.66 24.66 326,274
Jul 14, 2026 24.87 25.22 24.59 24.66 24.66 345,951
Jul 13, 2026 25.79 25.79 24.74 24.94 24.94 340,716
Jul 10, 2026 27.03 27.13 25.36 25.88 25.88 483,248
Jul 9, 2026 26.66 27.41 26.65 27.07 27.07 598,095
Jul 8, 2026 26.62 27.02 25.98 26.65 26.65 901,580
Jul 7, 2026 25.40 26.83 25.31 26.72 26.72 771,623
Jul 6, 2026 26.31 26.36 24.70 25.33 25.33 622,914
Jul 2, 2026 25.78 26.32 25.40 26.31 26.31 563,781
Jul 1, 2026 26.14 26.39 25.30 25.72 25.72 558,625
Jun 30, 2026 24.65 27.14 24.50 26.14 26.14 1,097,391
Jun 29, 2026 23.21 24.15 21.91 24.10 24.10 1,086,942
Jun 26, 2026 23.75 24.40 23.52 24.15 24.15 942,297
Jun 25, 2026 24.40 25.07 23.70 23.77 23.77 429,767
Jun 24, 2026 24.16 24.50 24.14 24.30 24.30 431,999
Jun 23, 2026 22.90 24.27 22.90 23.88 23.88 623,541
Jun 22, 2026 23.51 23.61 23.05 23.26 23.26 530,630
Jun 18, 2026 23.34 23.59 22.65 23.14 23.14 699,024
Jun 17, 2026 22.63 23.36 22.63 23.14 23.14 697,677
Jun 16, 2026 23.31 23.42 22.14 22.49 22.49 596,828
Jun 15, 2026 23.14 23.40 22.91 23.26 23.26 526,427
Jun 12, 2026 23.02 23.45 22.76 22.88 22.88 522,957
Jun 11, 2026 22.87 23.43 22.30 22.96 22.96 1,335,480
Jun 10, 2026 23.20 23.57 22.69 22.85 22.85 620,733
Jun 9, 2026 24.41 24.65 23.14 23.26 23.26 875,735
Jun 8, 2026 23.92 24.30 23.70 23.93 23.93 553,167
Jun 5, 2026 25.04 25.11 24.02 24.04 24.04 464,860
Jun 4, 2026 24.64 25.30 24.34 25.10 25.10 467,167
Jun 3, 2026 24.32 24.45 23.94 24.35 24.35 802,743
Jun 2, 2026 24.32 24.55 24.06 24.11 24.11 887,725
Jun 1, 2026 25.01 25.01 23.93 24.54 24.54 1,910,937
May 29, 2026 25.32 25.62 24.96 25.13 25.13 585,870
May 28, 2026 24.61 25.54 24.48 25.48 25.48 389,950
May 27, 2026 25.40 26.19 24.78 24.79 24.79 509,462
May 26, 2026 25.60 26.00 25.15 25.40 25.40 1,001,884
May 22, 2026 25.20 25.68 24.94 25.61 25.61 477,952
May 21, 2026 24.42 25.36 24.37 25.11 25.11 618,621
May 20, 2026 24.40 25.20 24.27 24.84 24.84 542,863
May 19, 2026 24.19 24.55 23.87 24.40 24.40 615,320
May 18, 2026 23.93 24.70 23.88 24.43 24.43 750,241
May 15, 2026 24.50 25.34 23.63 23.93 23.93 640,795
May 14, 2026 24.75 24.75 23.50 23.96 23.96 557,688
May 13, 2026 23.88 24.94 23.75 24.57 24.57 646,783
May 12, 2026 24.15 24.58 23.66 23.90 23.90 723,952
May 11, 2026 23.76 24.99 23.72 24.03 24.03 1,185,233
May 8, 2026 26.21 26.21 23.39 23.89 23.89 1,454,524
May 7, 2026 27.67 27.96 26.25 26.60 26.60 707,886
May 6, 2026 26.97 27.64 26.60 27.61 27.61 427,484
May 5, 2026 27.02 27.33 26.12 26.68 26.68 412,700
May 4, 2026 26.53 26.95 26.32 26.78 26.78 352,510
May 1, 2026 27.54 27.54 26.61 26.61 26.61 370,108
Apr 30, 2026 27.98 28.18 27.18 27.54 27.54 482,667
Apr 29, 2026 27.52 27.95 26.77 27.83 27.83 824,408
Apr 28, 2026 28.61 28.89 27.92 27.94 27.94 421,471
Apr 27, 2026 27.93 29.75 27.93 28.56 28.56 950,218
Apr 24, 2026 27.51 28.30 26.93 28.10 28.10 570,591
Apr 23, 2026 28.51 28.88 27.34 27.43 27.43 559,818
Apr 22, 2026 28.40 28.81 27.95 28.53 28.53 715,641
Apr 21, 2026 27.87 28.47 27.09 28.27 28.27 490,722
Apr 20, 2026 27.76 27.89 27.43 27.85 27.85 311,826
Apr 17, 2026 27.84 27.97 27.32 27.80 27.80 487,289
Apr 16, 2026 27.80 27.80 27.08 27.20 27.20 335,961
Apr 15, 2026 27.11 27.92 26.91 27.73 27.73 790,519
Apr 14, 2026 26.31 27.30 26.31 26.98 26.98 743,576
Apr 13, 2026 26.39 26.80 25.83 26.17 26.17 512,730
Apr 10, 2026 27.29 27.29 25.85 26.32 26.32 532,528
Apr 9, 2026 26.27 27.44 26.05 27.35 27.35 396,813
Apr 8, 2026 26.48 26.88 25.90 26.71 26.71 1,043,266
Apr 7, 2026 25.84 26.00 25.22 26.00 26.00 457,446
Apr 6, 2026 25.91 26.48 25.71 25.84 25.84 383,586
Apr 2, 2026 25.56 26.72 25.50 25.80 25.80 701,772
Apr 1, 2026 25.01 26.12 25.01 25.94 25.94 1,137,195
Mar 31, 2026 24.58 25.43 24.57 25.04 25.04 585,792
Mar 30, 2026 24.09 24.75 23.59 24.21 24.21 596,710
Mar 27, 2026 24.41 24.92 23.88 24.18 24.18 429,529
Mar 26, 2026 24.00 24.99 23.97 24.69 24.69 388,159
Mar 25, 2026 23.96 24.82 23.96 24.23 24.23 522,630
Mar 24, 2026 24.07 24.11 23.23 23.60 23.60 487,447
Mar 23, 2026 24.14 24.19 23.70 24.02 24.02 533,125
Mar 20, 2026 23.80 24.16 23.29 23.32 23.32 604,390
Mar 19, 2026 23.12 23.98 23.08 23.89 23.89 577,248
Mar 18, 2026 23.35 24.00 23.35 23.45 23.45 699,832
Mar 17, 2026 23.53 24.34 23.48 24.04 24.04 550,062
Mar 16, 2026 23.17 23.99 23.10 23.62 23.62 880,778
Mar 13, 2026 23.42 23.89 22.43 22.88 22.88 787,422
Mar 12, 2026 24.76 24.76 23.11 23.23 23.23 681,239
Mar 11, 2026 25.09 26.05 24.84 25.14 25.14 762,365
Mar 10, 2026 24.98 28.00 24.70 25.46 25.46 1,697,914
Mar 9, 2026 23.88 24.91 23.88 24.25 24.25 963,811
Mar 6, 2026 25.09 25.75 23.68 24.08 24.08 1,233,024
Mar 5, 2026 24.98 25.53 24.54 24.80 24.80 872,653
Mar 4, 2026 24.96 25.58 24.59 25.23 25.23 753,754
Mar 3, 2026 23.80 24.82 23.32 24.45 24.45 959,762
Mar 2, 2026 22.55 23.66 22.26 23.31 23.31 1,118,212
Feb 27, 2026 23.30 23.66 22.93 23.29 23.29 547,381
Feb 26, 2026 24.03 24.03 22.94 23.81 23.81 531,338
Feb 25, 2026 24.00 24.60 23.75 24.12 24.12 582,398
Feb 24, 2026 23.18 23.68 22.80 23.63 23.63 445,423
Feb 23, 2026 22.48 23.39 21.93 22.99 22.99 473,557
Feb 20, 2026 23.16 23.49 22.56 22.72 22.72 537,856
Feb 19, 2026 22.76 23.50 22.64 23.32 23.32 535,233
Feb 18, 2026 22.97 23.41 22.75 22.91 22.91 586,094
Feb 17, 2026 22.45 23.28 22.45 23.07 23.07 439,712
Feb 13, 2026 23.19 23.52 22.49 22.60 22.60 608,667
Feb 12, 2026 23.01 23.43 22.46 23.17 23.17 448,608
Feb 11, 2026 22.65 22.90 22.07 22.83 22.83 680,982
Feb 10, 2026 22.79 22.93 22.25 22.73 22.73 490,077
Feb 9, 2026 22.52 22.75 22.25 22.51 22.51 602,398
Feb 6, 2026 22.38 23.06 22.34 22.72 22.72 575,661
Feb 5, 2026 22.94 23.53 21.97 22.02 22.02 619,250
Feb 4, 2026 23.75 23.79 22.48 23.11 23.11 578,571
Feb 3, 2026 23.15 23.66 22.86 23.44 23.44 480,944
Feb 2, 2026 22.45 23.34 22.45 23.17 23.17 455,582
Jan 30, 2026 22.20 22.77 22.00 22.53 22.53 560,163
Jan 29, 2026 22.21 22.73 22.08 22.38 22.38 625,269
Jan 28, 2026 23.01 23.01 22.19 22.31 22.31 652,771
Jan 27, 2026 22.87 23.29 22.80 23.25 23.25 472,354
Jan 26, 2026 22.87 23.17 22.51 22.91 22.91 1,017,764
Jan 23, 2026 23.37 23.76 23.12 23.24 23.24 742,188
Jan 22, 2026 23.95 24.31 23.50 23.55 23.55 590,451
Jan 21, 2026 24.02 24.17 23.24 23.95 23.95 640,210
Jan 20, 2026 22.94 24.10 22.80 23.67 23.67 644,975
Jan 16, 2026 23.86 23.86 23.14 23.47 23.47 525,766
Jan 15, 2026 24.65 24.80 23.14 23.63 23.63 1,130,005
Jan 14, 2026 23.71 24.67 23.15 24.62 24.62 981,131
Jan 13, 2026 23.35 24.35 23.23 23.92 23.92 946,991
Jan 12, 2026 23.01 23.43 22.46 23.16 23.16 1,062,258
Jan 9, 2026 23.46 23.81 22.80 23.17 23.17 984,313
Jan 8, 2026 24.54 24.95 22.94 23.10 23.10 1,322,092
Jan 7, 2026 24.09 25.35 24.04 24.85 24.85 2,527,871
Jan 6, 2026 25.32 25.32 23.71 24.18 24.18 1,744,906
Jan 5, 2026 26.59 27.13 24.59 25.48 25.48 1,657,046
Jan 2, 2026 26.12 26.84 25.68 26.62 26.62 589,677
Dec 31, 2025 26.43 26.88 26.15 26.33 26.33 488,597
Dec 30, 2025 26.48 26.91 26.10 26.54 26.54 682,110
Dec 29, 2025 26.66 26.86 26.19 26.74 26.74 413,922
Dec 26, 2025 26.87 26.98 26.51 26.87 26.87 241,331
Dec 24, 2025 27.11 27.28 26.74 26.86 26.86 232,881
Dec 23, 2025 27.28 27.68 25.94 26.79 26.79 756,757
Dec 22, 2025 27.23 27.94 26.82 27.62 27.62 597,967
Dec 19, 2025 26.43 27.36 26.42 27.23 27.23 925,065
Dec 18, 2025 26.00 26.49 25.52 26.40 26.40 534,107
Dec 17, 2025 26.33 26.55 24.88 25.59 25.59 887,572
Dec 16, 2025 25.78 26.20 25.47 25.85 25.85 480,942
Dec 15, 2025 25.63 26.14 25.30 25.97 25.97 470,721
Dec 12, 2025 26.28 26.46 25.44 25.48 25.48 715,982
Dec 11, 2025 25.91 26.07 24.79 24.94 24.94 640,598
Dec 10, 2025 25.78 26.18 25.45 25.87 25.87 698,806
Dec 9, 2025 26.41 26.77 25.43 25.80 25.80 695,585
Dec 8, 2025 26.95 27.49 26.23 26.41 26.41 603,592
Dec 5, 2025 26.68 27.00 25.98 26.69 26.69 562,227
Dec 4, 2025 26.18 26.96 25.91 26.52 26.52 636,477
Dec 3, 2025 25.48 26.51 25.30 26.22 26.22 669,600
Dec 2, 2025 26.12 26.66 24.83 25.10 25.10 1,196,145
Dec 1, 2025 26.46 26.91 25.80 26.03 26.03 830,801
Nov 28, 2025 27.45 27.69 26.41 26.71 26.71 578,115
Nov 26, 2025 26.25 28.49 26.18 27.33 27.33 2,198,126
Nov 25, 2025 25.01 26.21 24.74 26.18 26.18 1,638,455
Nov 24, 2025 24.30 25.00 23.98 24.99 24.99 2,646,955
Nov 21, 2025 23.82 25.00 23.77 24.02 24.02 1,688,378
Nov 20, 2025 23.00 23.98 22.89 23.82 23.82 1,535,536
Nov 19, 2025 23.00 23.00 21.89 22.60 22.60 1,938,163
Nov 18, 2025 24.28 24.50 22.05 22.99 22.99 3,658,859
Nov 17, 2025 24.00 26.19 22.55 23.90 23.90 11,163,627
Nov 14, 2025 18.21 19.07 18.20 18.52 18.52 824,807
Nov 13, 2025 19.00 19.09 18.37 18.50 18.50 953,308
Nov 12, 2025 19.97 20.17 19.32 19.37 19.37 1,496,902
Nov 11, 2025 18.53 19.78 18.21 19.68 19.68 1,691,683
Nov 10, 2025 16.62 18.24 16.57 18.05 18.05 1,487,637
Nov 7, 2025 17.01 17.22 16.00 16.46 16.46 1,481,658
Nov 6, 2025 18.22 18.23 17.57 17.90 17.90 1,274,834
Nov 5, 2025 18.20 18.43 17.89 18.05 18.05 431,760
Nov 4, 2025 18.38 18.77 18.00 18.16 18.16 551,766
Nov 3, 2025 19.00 19.15 18.41 18.89 18.89 676,381
Oct 31, 2025 19.05 19.20 18.77 19.09 19.09 345,079
Oct 30, 2025 19.28 19.98 18.86 19.12 19.12 911,861
Oct 29, 2025 19.40 19.41 19.00 19.38 19.38 1,632,630
Oct 28, 2025 18.65 19.42 18.47 19.30 19.30 1,662,992
Oct 27, 2025 17.74 18.85 17.69 18.47 18.47 2,690,874
Oct 24, 2025 17.45 18.13 17.27 17.74 17.74 818,577
Oct 23, 2025 17.60 17.87 17.30 17.41 17.41 597,418
Oct 22, 2025 17.92 18.11 17.43 17.67 17.67 858,789
Oct 21, 2025 18.32 18.45 17.92 17.93 17.93 613,031
Oct 20, 2025 18.68 19.10 18.28 18.32 18.32 821,959
Oct 17, 2025 18.36 18.57 18.20 18.40 18.40 446,981
Oct 16, 2025 18.94 19.37 18.30 18.55 18.55 654,079
Oct 15, 2025 18.35 18.69 18.07 18.62 18.62 536,842
Oct 14, 2025 18.96 19.50 17.94 18.23 18.23 933,262
Oct 13, 2025 18.10 18.49 17.73 18.11 18.11 479,874
Oct 10, 2025 17.30 18.35 17.27 18.06 18.06 1,088,022
Oct 9, 2025 16.69 16.97 16.57 16.92 16.92 448,707
Oct 8, 2025 16.65 16.86 16.42 16.68 16.68 596,102
Oct 7, 2025 16.79 16.91 16.20 16.50 16.50 828,690
Oct 6, 2025 17.04 17.40 16.62 16.68 16.68 782,441
Oct 3, 2025 17.00 17.21 16.79 16.94 16.94 558,762
Oct 2, 2025 16.96 17.18 16.75 16.90 16.90 646,689
Oct 1, 2025 16.99 17.32 16.89 16.94 16.94 1,053,168
Sep 30, 2025 17.19 17.39 16.88 17.08 17.08 653,526
Sep 29, 2025 16.86 17.60 16.74 17.23 17.23 555,499
Sep 26, 2025 16.27 16.66 16.06 16.60 16.60 521,714
Sep 25, 2025 16.18 16.20 15.81 16.16 16.16 563,235
Sep 24, 2025 16.44 16.61 16.05 16.30 16.30 521,157

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Zymeworks Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ZYME, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation